Human embryo cryopreservation is now a fully established adjunct to as
sisted reproduction, with thawed embryos implanting at a rate approach
ing that of fresh embryos. As with fresh embryos, the quality of froze
n-thawed embryos is affected by patient age at the time of oocyte retr
ieval, and by culture conditions. Ovarian stimulation incorporating go
nadotropin-releasing hormone analogs does not appear to be detrimental
to cryopreservation success, and natural or artificial thaw cycles se
em equally effective. Successful cryopreservation seems feasible for o
ne- to eight-cell embryos and blastocysts using a variety of protocols
. Selection criteria for embryos to be frozen can vary, and embryo qua
lity has the most significant impact on post-cryopreservation viabilit
y. Unfertilized oocyte cryopreservation is coming closer to routine cl
inical application.